Neuronetics Inc (NRC F) stock market data APIs
€1.5894
0(0%)
as of January 19, 2026
Try our APIs with
free plan!
Neuronetics Inc Financial Data Overview
Price chart is built with
Anychart
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Prev. Close
1.5894
Open
1.5902
High
1.5933
Low
1.5857
52 wk Range
1.048-4.87
Market Cap
108 M
Shares Outstanding
68 486 K
Revenue
130 M
EPS
-0.29
Beta
0.659
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Neuronetics Inc data using free add-ons & libraries
Get Neuronetics Inc Fundamental Data
Neuronetics Inc Fundamental data includes:
- Net Revenue: 130 M
- EBITDA: -34 211 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-08-03
- EPS/Forecast: -0.24
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Neuronetics Inc News
New
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Neuronetics MALVERN, Pa., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products th...
Neuronetics to Report Second Quarter 2023 Financial and Operating Results and Host Conference Call
Neuronetics MALVERN, Pa., July 25, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products th...
Neuronetics Announces Expanded TMS Therapy Access Through Aetna® Health Plans
Neuronetics Policy Updates Impact Nationwide Commercial Plans for 16.8 Million Covered Lives MALVERN, Pa., July 19, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medi...
NeuroStar Achieves Milestone Regulatory Clearance in South Korea
Neuronetics First International Approval for Expanded Indication and Certification for MT Cap and D-Tect™ Technologies MALVERN, Pa., July 17, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: ST...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
